Dl. Kirkpatrick et al., SYNTHESIS AND BIOREDUCTIVE POTENTIAL OF A MONO-N-OXIDE DERIVATIVE OF THE ALKYLATING AGENT CHLORAMBUCIL, Anti-cancer drugs, 5(4), 1994, pp. 467-472
Chlorambucil N-oxide (CHLN-O) was synthesized and evaluated for in vit
ro bioreductive antitumor activity. A time-dependent hypoxic different
ial was observed when EMT6 cells were exposed to CHLN-O in the presenc
e of rat liver microsomes and reducing equivalents. The cytotoxicity o
f the N-oxide was potentiated under hypoxia, and augmented further by
a combination of low pH and hypoxia. Metabolic studies were also under
taken, which utilized previously described HPLC methodology for the an
alysis of CHLN-O loss from biological fluids. These demonstrated the r
equirement for microsomal enzymes and reducing equivalents, and also i
llustrated the time-dependent manner of CHLN-O loss from isolated micr
osomal preparations.